Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2005 AND VI 44 AND IP 4
Results: 9
1
2
Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase Formulations: The Past, the Present and Recommendations for the Future.
- Published in:
- Clinical Pharmacokinetics, 2005, v. 44, n. 4, p. 367, doi. 10.2165/00003088-200544040-00003
- By:
- Publication type:
- Article
3
Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.
- Published in:
- 2005
- By:
- Publication type:
- journal article
4
Pharmacokinetics of famotidine in infants.
- Published in:
- 2005
- By:
- Publication type:
- journal article
5
Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
- Published in:
- 2005
- By:
- Publication type:
- journal article
6
Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C.
- Published in:
- 2005
- By:
- Publication type:
- journal article
7
Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials.
- Published in:
- 2005
- By:
- Publication type:
- journal article
8
Practical Guidelines to Interpret Plasma Concentrations of Antiretroviral Drugs.
- Published in:
- Clinical Pharmacokinetics, 2005, v. 44, n. 4, p. 439, doi. 10.2165/00003088-200544040-00008
- By:
- Publication type:
- Article
9
The Authors’ Reply.
- Published in:
- Clinical Pharmacokinetics, 2005, v. 44, n. 4, p. 439
- By:
- Publication type:
- Article